The Stop TB Now Act is stalled in committee in the U.S. Senate after passing unanimously in the House. The bill provides for expansion of treatment for individuals infected with both tuberculosis ...

Drug-resistant TB is a "time bomb," said Dr. Masae Kawamura, who heads the Francis J. Curry National Tuberculosis Center in San Francisco, "a man-made problem that is costly, deadly, debilitating ...

Johnson & Johnson is allowing Stop TB Partnership, a Switzerland-based nonprofit, to distribute a generic version of its tuberculosis drug SIRTURO, or bedaquiline, in low- and middle-income ...

Johnson & Johnson expanded global access to tuberculosis drug this week amid novelist and YouTube star John Green joining an advocacy campaign.

Millions have died from tuberculosis, a preventable, treatable and curable disease. Congress can help end the death toll by passing the End TB Now Act.

Slashing tuberculosis aid could endanger millions of lives abroad, health authorities say, with potential consequences for the U.S., where TB cases have also been rising.

Doctors and aid workers warn that the freeze to USAID-funded TB programs is likely to cause thousands of unnecessary deaths and a rise in TB infections worldwide, and create the conditions for an ...

Lucica Dițiu, a Romanian doctor who has led the United Nations–hosted Stop TB Partnership for a dozen years, talked with Carmen about new diagnostics, a tuberculosis vaccine in the final ...

With the emergence of resistant TB, several private drug companies have started developing new treatments, but getting an entire regimen on the market could take 24 years.

DIslodged by COVID early in the pandemic, tuberculosis is once again the infectious disease that takes the most lives each year. And the number of cases set a new record. What's going on?

The United Nations-backed Stop TB Partnership said J&J's new price of $130 and Lupin's price of $194 for a six-month course of the treatment represented a 55% and 33% price reduction, respectively.

There is a popular phrase in public health circles that people are living with AIDS and dying of tuberculosis, or TB. Much of the health infrastructure for dealing with TB in low-income countries ...